GPCR - Structure Therapeutics Inc.
63.13
0.095 0.150%
Share volume: 624,070
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$63.04
0.00
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 08-08-2024 | 11-13-2024 | 02-27-2025 | 05-08-2025 | 11-06-2025 | 02-26-2026 | |
| Cash flow financing | 702.000 K | 514.703 M | -757.000 K | 615.000 K | 809.000 K | 56.203 M | 704.987 M | |
| Other financing cash flows | 755.000 K | 478.000 K | 397.000 K | 224.000 K | 809.000 K | -85.000 K | 3.140 M | |
| Cash flow | -31.960 M | 283.795 M | -209.497 M | -2.620 M | -17.387 M | -44.112 M | 696.711 M | |
| Net income | -26.036 M | -26.034 M | -33.977 M | -36.479 M | -46.833 M | -65.712 M | 33.004 M | |
| Depreciation | 222.000 K | 232.000 K | 265.000 K | 273.000 K | 274.000 K | 356.000 K | 412.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 1.418 M | -204.515 M | -189.044 M | 33.232 M | 34.033 M | -49.319 M | 56.140 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 5.091 M | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 162.000 K | 427.000 K | 685.000 K | 16.000 K | 314.000 K | 1.572 M | 1.496 M | |
| Cash Change | -31.960 M | 283.795 M | -209.497 M | -2.620 M | -17.387 M | -44.112 M | 696.711 M |